| breast cancer - triple negative | ||
| es-BC - TNBC - NA - all population | es-BC - TNBC - NA - PDL1 positive | |
| atezolizumab based treatment | ALEXANDRA/IMpassion-030 | |
| atezolizumab plus carboplatin plus nab-paclitaxel | NeoTRIPaPDLA | |
| atezolizumab plus nab-paclitxel followed by doxorubicin plus cyclophosphamide | IMpassion-031 ... | IMpassion-031 ... |
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
